ACLS Stock Recent News

BEVERLY, Mass. , April 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the first quarter 2025 before the opening of the market on Tuesday, May 6, 2025.

Kulicke and Soffa, Axcelis and Veeco have been highlighted in this Industry Outlook article.

The Zacks Electronics - Manufacturing Machinery industry participants, such as KLIC, ACLS and VECO, are benefiting from increased capital spending on high-performance computing, advanced packaging and memory.

While the largest companies in the world rightfully grab the most attention when they announce buyback authorizations, small caps also deserve recognition for their plans to return capital to shareholders. Small caps are generally defined as stocks with market capitalizations between $250 million and $2 billion.

Axcelis (ACLS 0.52%) is a beaten-down semiconductor stock that could be interesting for long-term investors.

President and CEO Russell Low will Present Keynote Speech at CS Asia BEVERLY, Mass. , March 17, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that it will be the Diamond Sponsor for the Compound Semiconductor Asia Conference (CS Asia) 2025.

The latest trading day saw Axcelis Technologies (ACLS) settling at $58.47, representing a +0.52% change from its previous close.

BEVERLY, Mass. , March 12, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that its Board of Directors has approved an additional $100 million in share repurchase authorization.

Axcelis faces challenges in the EV market and China but has strong long-term prospects due to SiC demand, AI, and cloud technologies. The company's financial stability, low debt, and undervaluation present a 21% upside, making Axcelis a "Buy" with a target price of $78. Despite a revenue drop in 2024, Axcelis' diversified segments and high-margin CS&I services ensure resilience and future growth.

BEVERLY, Mass. , Feb. 18, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: The Susquehanna Financial Group Fourteenth Annual Technology Conference, taking place at the Lotte New York Palace Hotel on February 27 and 28, 2025.